scispace - formally typeset
Open AccessJournal ArticleDOI

An industry analysis of pharmaceutical production in South Africa

Reads0
Chats0
TLDR
The purpose of this research is to investigate the shifting structure of pharmaceutical production in South Africa and examine the global and local factors that have contributed to this change.
Abstract
The purpose of this research is to investigate the shifting structure of pharmaceutical production in South Africa and examine the global and local factors that have contributed to this change. Generally, these factors have resulted in a decline in the number of pharmaceutical manufacturers in South Africa and in particular manufacturing operations owned by multinational companies. Simultaneously the global demand for generic medicines has increased due to their ability to improve access to affordable medicines. As a result, the supply of medicines in South Africa is being increasingly met by imported generic medicines and to a lesser extent locally manufactured generic medicines. These changes, together with a turbulent and sometimes uncertain regulatory environment, have led to interesting dynamics and changes within the structure of the pharmaceutical manufacturing industry in South Africa.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Sovereignty Under Siege: Corporate Challenges to Domestic Intellectual Property Decisions

TL;DR: A detailed analysis of Eli Lilly's case of first impression can be found in this article, along with a prediction of other likely impending threats to domestic regulation of public health that intersect with the interests of pharmaceutical companies.
Journal ArticleDOI

Originator and generic medicine: Pricing and market share.

TL;DR: Investigations into the prices of the originator brands indicate that the number of generics available in a specific market has a significant positive impact on the relative price of originators, thereby making originators relatively more expensive compared to their generic rivals.
Journal ArticleDOI

Strategic sourcing in Africa: the case for the labor market

TL;DR: In this paper, the impact of the labor market on the integration of Africa into the global supply chain (GSC) was analyzed using qualitative content analysis methodology, and the potential of Africa's supply of low-cost labor market and its integration in the GSC was discussed.
References
More filters
Journal ArticleDOI

An empirical analysis of sustained advantage in the U.S. pharmaceutical industry: impact of firm resources and capabilities

TL;DR: In this paper, the authors test a model of the relationships among firm resources, firm capabilities, and sustained competitive advantage between 1971 and 1989, and find that R&D and salesforce expenditures have indirect and direct effects, respectively, on sustained competitive advantages.
Journal ArticleDOI

Pricing, Profits, and Technological Progress in the Pharmaceutical Industry

TL;DR: The authors examines the phenomena that precipitated the current pharmaceuticals debate, their historical antecedents, and the principal questions at issue, concluding that a pell-mell march toward regulation of pharmaceutical industry pricing could seriously impair the industry's incentives for investment in new products.
Journal ArticleDOI

The Changing Structure Of The Pharmaceutical Industry

TL;DR: The creation of a market for biomedical science and increased vertical competition within the industry are likely to spur innovation and raise productivity, but they also could induce socially wasteful spending and weaken academic science.
Journal ArticleDOI

The urge to merge in the pharmaceutical industry

TL;DR: In this article, a case study of the Glaxo Wellcome and SmithKline Beecham merger is presented, where the authors analyze the growth of the pharmaceutical industry, its business system and value chain.
Journal Article

Health care financing and expenditure : framework for transformation

TL;DR: The NHA data highlight several key features of lbgprivatel/bg health sector development in the post-apartheid era that suggest an overall decline in value-for-money in the private sector, at least prior to the implementation of the Medical Schemes Act of 1998.
Related Papers (5)